News Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 6, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 6, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
May 2, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--May 2, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
May 2, 2019Total Revenue Increased 16% Year-over-Year
BEDFORD, Mass.--(BUSINESS WIRE)--May 2, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on its...
-
Apr 30, 2019Seasoned commercial leader to oversee hybrid commercial organization and upcoming launch of Bone Repair Surgical Therapy in the U.S.
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 30, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Apr 18, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its first-quarter 2019 financial results after the close of...
-
Apr 3, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Apr. 3, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Mar 18, 2019Industry veteran brings extensive experience leading high-performing R&D groups
BEDFORD, Mass.--(BUSINESS WIRE)--Mar. 18, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Mar 11, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Mar. 11, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedics and regenerative medicines company specializing in therapeutics based on...
-
Feb 21, 2019Strong Bottom Line Performance with $0.54 Diluted EPS for Fourth Quarter of 2018
BEDFORD, Mass.--(BUSINESS WIRE)--Feb. 21, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic and regenerative medicines company specializing in therapeutics based on...
-
Feb 7, 2019
BEDFORD, Mass.--(BUSINESS WIRE)--Feb. 7, 2019-- Anika Therapeutics, Inc. (NASDAQ: ANIK) today announced that the Company plans to issue its fourth-quarter and full-year 2018 financial results...